Beta Galactosidase Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Beta-galactosidase (GLB1) is a lysosomal hydrolase encoded by the GLB1 gene. It catalyzes the hydrolysis of terminal galactose residues from various glycoconjugates, including GM1 ganglioside and keratan sulfate. This enzyme is essential for normal lysosomal function and its deficiency causes GM1 gangliosidosis. [@lysosomal2023]
Beta Galactosidase Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Beta-galactosidase (GLB1) is a lysosomal hydrolase encoded by the GLB1 gene. It catalyzes the hydrolysis of terminal galactose residues from various glycoconjugates, including GM1 ganglioside and keratan sulfate. This enzyme is essential for normal lysosomal function and its deficiency causes GM1 gangliosidosis. [@lysosomal2023]
Protein Information
Structure
Beta-galactosidase forms a homotetramer:
Each subunit: ~60 kDa
Active site: Contains a glutamate residue as the catalytic nucleophile
Glycosylation: Heavily N-glycosylated for proper lysosomal targeting
Normal Function
The enzyme catalyzes hydrolysis of:
GM1 ganglioside → GM2 ganglioside + galactose
Keratan sulfate → N-acetylglucosamine + galactose
Other galactose-containing glycoconjugates
In [neurons](/entities/neurons), proper GM1 ganglioside turnover is essential for:
Synaptic function
Neuronal signaling
Membrane microdomain integrity
Role in Neurodegeneration
GM1 Gangliosidosis
Accumulation of GM1 ganglioside in neurons causes:
Pharmacological chaperones to enhance residual enzyme activity:
Migalastat (approved for Fabry disease)
2-hydroxypropyl-beta-cyclodextrin (experimental)
Background
The study of Beta Galactosidase Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.